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Abstract 
While screening Le(a+b+) Polynesian DNA samples for a candidate Sew allele, a 
point mutation (C5”+T) resulting in a new stop codon (Arg19’+stop) in the 
a( 1,2)fucosyltransferase gene (FUT2) was identified. This point mutation result- 
ed in the gaining of a new restriction enzyme cleavage site (DdeI), which allowed 
restriction enzyme cleavage screening of 40 selected Polynesians and 42 random 
Caucasians. The nonsecretor phenotype in two of the three nonsecretor Polyne- 
sians analyzed was due to homozygosity for the ‘new’ mutation, whereas the 
third Polynesian nonsecretor (with Caucasian ancestors) was due to homozygos- 
ity of the ‘old’ (Tq~’~~+stop)  mutation. The nonsecretor phenotype in all Cauca- 
sians analyzed was a consequence of homozygosity for the ‘old’ mutation. Both 
the new and the old nonsecretor mutations were identified in the heterozygous 
state in some secretor-positive Polynesians, while only the old mutation was 
found in the heterozygous state in Caucasians of the same phenotype. ..................... 
Introduction 
Expression of type 1 ABH and Le” blood group antigens 
in human exocrine secretions is determined by the presence 
of a secretor (Se) gene [reviewed in ref 11. The term ‘secre- 
tor’ strictly refers to the ability to make large amounts of 
soluble A, B and H determinants, usually detected in saliva, 
with the ABH substances found being dependent on the 
ABO blood group of the individual [2]. The relative expres- 
sion of the Lea or Le” antigens is dependent not only on the 
Lewis genotype but also on the individual’s genetically in- 
dependent secretor genotype. Fucosyltransferases coded by 
Lewis and secretor genes thus compete with each other and 
with other glycosyltransferases to determine the Lewis and 
secretor phenotypes of an individual. In Lewis-negative in- 
dividuals, the secretor genotype does not affect the Lewis 
phenotype, but in Lewis-positive individuals, the nonsector 
genotype generates the Le(a+b-) red cell phenotype, the se- 
cretor genotype causes the Le(a-b+) red cell phenotype, 
and the partial-secretor genotype gives rise to the Le(a+b+) 
red cell phenotype [reviewed in ref 31. 
Genetic, biochemical and molecular analyses indicate 
that the Se gene, termed FUT2 in the Genome Data Base, 
corresponds to an a(l,2)fucosyltransferase gene distinct 
from the H blood group a( 1,2)hcosyltransferase [4-81. The 
recent identification and sequencing of the Se gene predicts 
a 332-amino-acid-long polypeptide sharing 68% sequence 
identity with the COOH-terminal292 residues of the human 
H blood group a(1,2)fi~cosyltransferase. A nonsecretor al- 
lele, causing the Le(a+b-) phenotype in Lewis-positive in- 
dividuals, corresponded with the homozygous presence of 
an enzyme-inactivating nonsense point mutation ( T ~ P ’ ~ ~  
+stop) at this locus [9]. 
0 1996 S.Karger AG, Basel Dr. Steve Henry Received. 
KARGER 0042-900719610701~002l $10.0010 Department ofClinical Chemistty and Transfusion Medicine June 9,1995 
E-Mail kargerh, karger.ch Goteborg University Accepted: 
Fax+4l61 306 12 34 Sahlgrenska Hospital July 7.1995 
S-413 45 Goteborg (Sweden) 
Determination of secretory phenotypes is usually done 
serologically by inhibiting ABH antiserum with saliva. In 
Lewis-positive individuals, it is sometimes deduced from 
the direct red cell agglutination test, because Le(a-b+) and 
Le(a+b-) red cell phenotypes correlate with secretor and 
nonsecretor salivary phenotypes, respectively. These tech- 
niques, however, may be inaccurate, particularly in certain 
circumstances (e. g. pregnancy, disease, transfusion, trans- 
plantation) and in some populations (e. g. Polynesians [3], 
Asians [lo], Australian aborigines [ll]), and so may not 
necessarily accurately reflect the genotype of an individual 
[reviewed in ref 31. Genotyping now offers the opportunity 
to determine the secretor status of an individual without the 
requirement to phenotype. However, before this can hap- 
pen, all alleles should be identified. 
In this paper we report the presence of a second FUT2 
nonsecretor allele (Arg”’+stop) which in homozygous 
form correlates with the salivary ABH nonsecretor and red 
cell Le(a+b-) phenotype in two Polynesian Lewis-positive 
individuals. 
Materials and Methods 
Samples and Phenotypes 
The 40 Polynesian samples were mostly from previous studies 
where they were selected on the basis of unusual red cell phenotypes. 
These samples have been extensively Lewis and secretory phenotyped 
and in some instances glycolipids were immunochemically profiled 
[ 12-1 51. Lewis phenotypes reported are those based on red cell serol- 
ogy; however, for 3 samples, the Le(a+b)  phenotype was not support- 
ed by glycolipid analysis of plasma [15, unpubl. obs.]. These 3 samples 
(033, 057 and 114) are examples of the Le(a+b+) phenotype in which 
the Leb reaction on red cells cannot be serologically demonstrated rou- 
tinely, and these samples have been classified here as Le(a+b+). 
The Caucasian samples were predominantly from another study of 
Swedish blood donors [ 161, and although they had been selected on the 
basis of being predominantly Lewis negative (l6/42), no selection was 
made for secretor phenotypes. The Swedish Caucasian samples were 
Lewis phenotyped on red blood cells with monoclonal Lewis reagents 
(Dominion Biologicals, Dartmouth, Canada) and the Lewis-negative 
samples were salivary ABH phenotyped as described elsewhere [17]. 
DNA Preparation 
The DNA preparation technique was essentially according to Mill- 
er et al. [18]. After lysis of the erythrocytes, the remaining leukocytes/ 
nuclei were treated with proteinase Kin EDTA buffer with SDS. After 
addition of 5 M NaCI, DNA was extracted from the supernatants by 
precipitation, washing and drying, and finally dissolved to a concen- 
tration of approx 500 pg/ml in TE buffer (10 mMTris-HCI, I mMNa2- 
EDTA, pH 7.5). 
PCR Amplijkation 
PCR amplification was performed on a PTC-100 Programmable 
Thermal Controller (MJ Research, Watertown, USA). Half a micro- 
gram of genomic DNA was used as template for each amplification 
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reaction. The primers were purchased from Scandinavian Synthesis, 
Koping, Sweden, and diluted in sterile water to 25 pMfor PCR ampli- 
fication, and to 0.5 pM for nucleotide sequencing. 
All PCR amplifications were done with heating to 85°C for 5 min 
before adding 1 U Taq DNA polymerase ( 5  U/pI, No. 1435 094, Boehr- 
inger Mannheim, Mannheim, Germany). PCR amplification was run 
for 30 cycles with denaturation at 94°C for 1.5 min, annealindexten- 
sion for 2.5 min at 72°C and stopped by cooling to 8°C [9]. 
All PCR products and fragments after restriction enzyme cleavage 
were analyzed by agarose gel electrophoresis in TBE buffer (45 mM 
Tris borate, 1 mMNa2-EDTA, pH 8.0) with 5 pI ethidium bromide and 
run at 125 V The molecular-weight marker used was the MspI digest of 
pBR322 DNA (No. 73318, United States Biochemical, Cleveland, 
Ohio, USA). 
Nucleotide Sequencing 
PCR-amplified FUT2 gene segments were separated on a 2% Nu- 
Sieve@ GTG@ agarose gel (No. 50082, FMC BioProducts, Rockland, 
Me., USA). The bands were excised, melted and extracted with TE 
buffer (20 mM Tris-HCI, 1 mM Na2-EDTA, pH 7.8), partitioned with 
phenol and the DNA was extracted and precipitated with ethanol. A 
DNA sequencer model 373A (Applied Biosystems, Calif., USA) and 
the DyeDeoxyTM terminator cycle sequencing technique (No. 401095, 
Perkin Elmer-Cetus, Calif., USA) were used according to the manu- 
facturer’s protocol with Taq DNA and the cyclic amplification reaction 
run for 15 sat  96”C, 1 sat  5 0 T ,  4 min at 60°C and stopped at 4°C after 
25 cycles. The products were purified by repeated phenol-chloroform 
extractions, chloroform extraction, precipitation, centrifugation, 
washing in ethanol and drying. Finally, the samples were dissolved in 
6 pl of deionized formamide (No. 72020, IBI, New Haven, Conn., 
USA) containing 50 mMNa2-EDTA 5:1 (vol/vol) and 3% blue dextran 
(no. D-5751, Sigma, St. Louis, Mo., USA), heated for 2 min at 95”C, 
cooled on ice and loaded onto 6% polyacrylamide sequencing gels. 
Mutation Screening with Restriction Enzyme Cleavage 
Restriction enzyme BstNI (10 U/pI, No. 168 S, New England Bio- 
labs, Beverly, Mass., USA) cleavage identification of the Trp’43+stop 
(nucleotide G428+A) mutation was used with PCR products obtained 
from the primers as described elsewhere [9]. Restriction cleavage 
products were separated on a 4% NuSieve GTG agarose gel. 
Restriction enzyme DdeI (10 U/pI, No. 835293, Boehringer Mann- 
heim) cleavage for the Arg”’+stop (nucleotide C5”-+T) mutation 
was used with PCR products obtained from the BstNl sense primer 
(as above) and a new antisense primer 5’-CGTCCCAATGGTCAT- 
GATGGTGTGGTTACA-3’. DdeI cleavage reactions were performed 
at 37°C for 2 h and the reactions were stopped with gel-loading solu- 
tion (G 2526, Sigma). Restriction cleavage products were separated on 
a 2% agarose gel (No. 15510427, Gibco-BRL, Paisley, UK). 
Results 
The coding sequence of the FUT2 gene of 13 individuals 
[lo Polynesians: 9 Le(a+b+) and 1 Le(a-b-) partial secretor; 
3 Caucasians: 2 Le(a+b-) and 1 Le(a-b-) secretor] were 
completely sequenced (both strands). Heterozygosity (C 
and T) of the nucleotide sequence at position 571 (wild type 
corresponding to Arg’”) was found in 3 Polynesian sam- 
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Table 1. Presence and zygosity of the 
BsrNI-determined se4” allele and the Ddel- Red cell Lewis n se4** se5” Un- 
determineds2” allele in each Lewis and 
salivary phenotype for Polynesians and Cau- 
casians Polvnesians 
mutated homo hetero homo hetero phenotype 
Secretors Le(a-b+) 18 0 2 0 3 13 
Le(a+b+)a 14 0 I 0 3 10 
Le(a-b-) 5 0  0 0 0 5 
Nonsecretors Le(a+b-) 2 0  0 2 0 0 
Le( a - b )  1 1  0 0 0 0 
~~ 
Caucasians 
Secretors Le(a-b+) 20 0 13 0 0 I 
Le(a-b-) 10 0 6 0 0 4 
Nonsecretors Le(a+b) 6 6  0 0 0 0 
Le( a-b-) 6 6  0 0 0 0 
Secretors include both normal and partial secretors. homo = Homozygous state of mutated 
Includes 3 individuals whose red cells phenotype as Le(a+b-) but by glycolipid analyses are 
allele; hetero = heterozygous state of mutated allele. 
Le(a+b+). 
ples. Translation of this (C’’’3T) mutation revealed the co- 
don would read as a stop. The mutation also resulted in the 
gain of a new restriction enzyme cleavage site for DdeI. 
All available samples were screened with the appropriate 
restriction enzymes for both the se428 TRP’43+stop) and 
seS7’ (Arg”’+ stop) mutations (table 1). The BstNI restric- 
tion enzyme cuts a 195-base pair (corresponding to nucleo- 
tides 370 to 564) PCR product ofthe secretor allele (Se) into 
four fragments (101, 57, 25 and 12), while the nonsecretor 
allele (se4”) is identified by the loss of a restriction site and 
results in three fragments (101, 82 and 12; fig. I ) .  The DdeI 
restriction enzyme does not cut a 468-base pair (corre- 
sponding to nucleotides 370 to 837) PCR product of the se- 
cretor allele while the nonsecretor allele (se’”) is identified 
by a restriction site resulting in two fragments (267 and 201; 
The se4” mutation was found in a homozygous state in 
all 6 Le(a+b-) and all 6 Le(a-b-) nonsecretor Caucasians 
and in a heterozygous state in 10 of 30 secretor individuals. 
The remaining 11 secretor individuals were all wild type. 
The se428 mutation was also found in Polynesians but only in 
3 of 37 secretors and homozygously in 1 Le(a-b-) nonsecre- 
tor. The se428 mutation was not present in the two Le(a+b-) 
nonsecretor individuals. 
In contrast the se571 mutation was absent from the Cauca- 
sians but present among Polynesians. This mutation was 
found in a homozygous state only in the two Le(a+b-) non- 
secretor Polynesians (and confirmed by sequencing), and 
was present in a heterozygous state in 3 of 14 Le(a+b+) par- 
fig. 1). 
tial secretors, and in 3 of 18 Le(a-b+) secretor individuals. 
No individual had both the DdeI- and BstNI-determined se 
alleles. 
Discussion 
The common distinction between secretors and nonse- 
cretors of ABH andor  Lewis substances is made by inhib- 
iting an antiserum agglutinin reaction with saliva. Many 
variables influence the detection of salivary substances. 
These include the ethnic group of the donor, ABO and Le- 
wis genotype, saliva collection method and antiserum used. 
Determination of the salivary ABH secretor phenotype, es- 
pecially in some populations, can be difficult, if not impos- 
sible with routine serological techniques [reviewed in 
ref. 31. Furthermore, the inconvenience and reluctance of 
donors to produce a suitable saliva sample adds to the diffi- 
culty of secretor phenotyping. With the recent identification 
of the coding sequence for the secretor gene [9], restriction 
enzyme cleavage assays for nonsecretor allele genotyping 
offer an attractive alternative to salivary and red cell pheno- 
typing. However, as seen here, an alternative nonsecretor 
allele exists among Polynesians which would not have been 
detected with the method used for detecting the common 
se428 (T~-p’~~+stop) Caucasian nonsecretor mutation. 
In this paper, the second nonsecretor allele, se5” 
(Arg”’-+stop), was found while screening for a candidate 
Sew allele. Subsequent restriction enzyme analysis revealed 
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Fig. 1. Examples of the PCR-restriction enzyme cleavage products for the BstN1-deter- 
mined se428 allele and the Ddel-determined seS7' allele. The ~e~~~ allele is characterized by the 
absence of enzyme cleavage of the 82-base pair fragment into 57- and 25-base pair fragments. 
The seS7' allele is characterized by enzyme cleavage of a 468-base pair fragment into 201- and 
267-base pair fragments. PCR = The uncleaved PCR product of sample 125; M = Mspl digest of 
pBR332 molecular-mass marker. 
Lane Individual Serological Secretor Restriction enzyme Genotype 
phenotype (Lewis) status' cleavageb 
BstNI DdeI 
+I+ se571 se571 I 125 Le(a+b-) NS -1- 
I1 128 Le(a-b+) S -I- -I+ Se s2" 
Ill  Hen Le(a+b-) NS +I+ -I- 
IV 1 I3 Le( a-b+) S -/+ -1- Se se42m 
se428 se42X 
a S = Secretor; NS = nonsecretor. 
-1- = Homozygous negative; +I+ = homozygous positive; +/- = heterozygous. 
that this new mutation was present only in the Polynesian 
samples and when in a homozygous state correlated with 
the red cell Le(a+&) salivary nonsecretor phenotype. In Po- 
lynesians, most of the apparently phenotypically Le(a+&) 
individuals are in fact Le(a+b+). Detection of the true Le 
(a+&) nonsecretor phenotype requires testing with antise- 
rum known to detect weak Leb expression and carefully 
standardized salivary inhibition assays [12]. The two Le 
(a+&) Polynesian samples in this study were determined by 
thorough serological analyses. 
The Caucasian se428 nonsecretor allele [9] was present 
with a frequency equal to the expected gene frequency of 
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this allele in the predominantly Swedish sample. This allele 
was also found in Polynesians but much less frequently. 
Furthermore, each of the four Polynesians who had the se42x 
nonsecretor allele also had a Caucasian ancestor within the 
last two generations. Because of the selected nature of the 
Polynesian samples in this study, it is not adequate to esti- 
mate gene frequency, but the results suggest that the se428 
nonsecretor allele is an infrequent allele in Polynesians 
compared to Caucasians. 
The new point mutation (CS7I+T) identified in the FUT2 
gene resulted in Arg"'+ stop (numbered from the putative 
initiator methionine [9 ] ) .  This mutation is predicted to trun- 
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cate a large part (141 amino acid residues) of the enzyme 
catalytic domain on the COOH terminal segment. The evi- 
dence that this mutation yields an inactive allele comes 
from the fact that this mutation was found in a homozygous 
state in two known Polynesian red cell Le(a+b)  nonsecre- 
tor individuals who did not have the Caucasian se42x muta- 
tion. Furthermore, the new nonsense Polynesian mutation 
was not found in homozygous form in any of the secretor or 
partial-secretor individuals. No Caucasian individual had 
the seC7’ mutation. 
To date, at least one coding secretor allele Se, and two 
noncoding alleles (termed se428 and se5”) are known. Fur- 
ther mutations are expected as we have found partial secre- 
tors with the red cell Le(a+b+) phenotype who cannot be 
explained on the basis of these alleles. Molecular genotyp- 
ing for secretor should now be done in parallel with routine 
red cell and saliva phenotyping in order to establish the re- 
liability of genotyping, before it can replace saliva pheno- 
typing. 
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